Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program (Q28201111)

Journal of the American Academy of Nurse Practitioners

Europe PubMed Central

title

Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program (English)

0 references

main subject

cardiovascular disease

1 reference

Lawrence Blonde

1

0 references

Judith Dempster

series ordinal

2

0 references

Joanne M Gallivan

series ordinal

3

0 references

Elizabeth Warren-Boulton

series ordinal

4

0 references

language of work or name

English

0 references

publication date

November 2006

0 references

published in

0 references

volume

18

0 references

issue

11

0 references

page(s)

524-33

0 references

cites work

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111/J.1745-7599.2006.00171.X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1745-7599.2006.00171.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1745-7599.2006.00171.X

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1745-7599.2006.00171.X

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1745-7599.2006.00171.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Weight change and diabetes incidence: findings from a national cohort of US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels. HIT Investigators. Department of Vete

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Obesity, insulin resistance, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00171.X

10.1111/J.1745-7599.2006.00171.X

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4402318

4402318

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference